ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

UEEC United Health Products Inc (PK)

0.1763
-0.0036 (-2.00%)
06 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
United Health Products Inc (PK) USOTC:UEEC OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0036 -2.00% 0.1763 0.0001 0.45 0.1897 0.1727 0.1727 136,310 21:19:35

Current Report Filing (8-k)

21/10/2014 7:53pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report; date of earliest event reported: October 21, 2014

 

UNITED HEALTH PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

814-00717

 

84-1517723

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

10624 S. Eastern Ave., Ste. A209

Henderson, NV 89052

(Address of principal executive offices, zip code)

 

(877) 358-3444

(Registrant’s telephone number, including area code)

 

c/o Morse & Morse, PLLC, 1400 Old Country Road, Suite 302, Westbury, NY 11590

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))

 

 

 

 

Item 8.01 Other Events

 

The Company’s principal executive office is now located at 10624 S. Eastern Ave., Suite A209, Henderson, NY 89052, Tel: 877-358-3444; Fax: 866-878-4544; Email: info@unitedhealthproductsinc.com; Website: www.unitedhealthproductsinc.com.

 

 
2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

UNITED HEALTH PRODUCTS, INC.

 
       

Dated: October 21, 2014

By:

/s/ Douglas Beplate

 
   

Douglas Beplate

 
   

Chief Operating Officer

 

 

 

 

3


 

1 Year United Health Products (PK) Chart

1 Year United Health Products (PK) Chart

1 Month United Health Products (PK) Chart

1 Month United Health Products (PK) Chart

Your Recent History

Delayed Upgrade Clock